HERAEUS MEDICAL GMBH v. ESSCHEM, INC.
2:14-cv-05169
E.D. Pa.Jun 6, 2017Background
- Heraeus Medical GmbH (German) develops bone cements (Palacos); Biomet was a former distributor and later competitor after 2005.
- Biomet contracted Esschem (Pennsylvania) in 2004 to develop copolymers (R262, R263) used in Biomet’s bone cement; Esschem sold those copolymers to Biomet.
- Heraeus sued Esschem (2014) alleging Esschem knowingly misappropriated Heraeus trade secrets to develop copolymers for Biomet; Heraeus sought to add Biomet as a defendant.
- Motion to amend to add Biomet was filed more than two years after the original complaint and about one month before the close of discovery.
- Esschem and Biomet opposed amendment, arguing undue delay and prejudice (additional discovery, motions, and repeat of transnational discovery), and Biomet would lack participation as a newly named defendant.
- The Court denied leave to amend, concluding amendment would be prejudicial and unduly delayed; it declined to reach futility or dilatory motive and rejected joinder under Rule 19.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether leave to amend complaint to add Biomet should be granted under Fed. R. Civ. P. 15(a) | Heraeus: Justice requires amendment; Biomet’s prior involvement and discovery mitigates prejudice; German judgment uncertainty justified timing | Esschem/Biomet: Motion is too late; adding Biomet would cause substantial prejudice, extra discovery, new motions, and delay | Denied — amendment would prejudice defendants and unduly delay litigation |
| Whether Heraeus’s delay in moving to amend was excusable | Heraeus: Believed German judgment might have preclusive effect; withholding of certain evidence justified delay | Defs: Heraeus knew Biomet’s role from the start and previously sued Biomet elsewhere; no adequate explanation for late amendment | Denied — Heraeus failed to justify nearly two-plus years' delay and five-month waiting after preclusion ruling |
| Whether joinder of Biomet is required under Rule 19 | Heraeus: Biomet indemnifies Esschem and its interests would be impaired if not joined | Biomet: Did not assert an interest claiming inability to protect itself; joinder typically invoked by defendants | Denied — Rule 19 not applicable; absent party has not claimed an interest necessitating joinder |
| Whether amendment would be futile or reflect bad faith/dilatory motive | Heraeus: Did not primarily argue futility; sought to correct parties sued | Defs: Suggested motions to dismiss likely and added burden; raised prejudice and delay | Court did not decide futility or bad faith because prejudice/undue delay dispositive |
Key Cases Cited
- Long v. Wilson, 393 F.3d 390 (3d Cir. 2004) (factors for denying leave to amend)
- Lundy v. Adamar of N.J., Inc., 34 F.3d 1173 (3d Cir. 1994) (standard for amendment and denial factors)
- Foman v. Davis, 371 U.S. 178 (U.S. 1962) (leave to amend should be freely given but may be denied for prejudice, undue delay, bad faith, or futility)
- Cureton v. Nat’l Collegiate Athletic Ass’n, 252 F.3d 267 (3d Cir. 2001) (denial of amendment for prejudice and undue delay)
- Berger v. Edgewater Steel Co., 911 F.2d 911 (3d Cir. 1990) (late amendment after discovery close can unfairly burden court and parties)
- Bjorgung v. Whitetail Resort, LP, 550 F.3d 263 (3d Cir. 2008) (delay becomes undue when prior opportunities to amend were available)
- Langbord v. United States Dep’t of Treasury, 832 F.3d 170 (3d Cir. 2016) (courts focus on reasons for not amending sooner)
- CMR D.N. Corp. v. City of Philadelphia, 703 F.3d 612 (3d Cir. 2013) (significant unjustified delay may itself be prejudicial)
- Glancy v. Taubman Centers, Inc., 373 F.3d 656 (6th Cir. 2004) (plaintiff generally chooses parties; Rule 19 often a defendant's tool)
- Alpha Pro Tech, Inc. v. VWR Int’l LLC, 984 F. Supp. 2d 425 (E.D. Pa. 2013) (absent party must claim an interest to mandate joinder)
